ReviewWorld journal of gastroenterology2026
Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials.
Sara Ascari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it